Liton Technology Corp. (TPEX:6175)

Market Cap	5.06B
Revenue (ttm)	4.36B
Net Income (ttm)	474.05M
Shares Out	149.72M
EPS (ttm)	3.20
PE Ratio	10.57
Forward PE	n/a
Dividend	1.75 (5.13%)
Ex-Dividend Date	Jul 10, 2025

Volume	6,000
Average Volume	482,033
Open	34.40
Previous Close	33.80
Day's Range	34.00 - 35.30
52-Week Range	28.35 - 47.50
Beta	0.98
RSI	47.40
Earnings Date	Aug 8, 2025

About Theseus Pharmaceuticals

Liton Technology Corp. manufactures and sells etched and formed aluminum foils in Mainland China, Europe, the Americas, Japan, Korea, India, Southeast Asia, Malaysia, Indonesia, and internationally. The company offers low, medium, and high voltage formed aluminum foils for anode specification; low voltage aluminum etched foils; and TAB foils. Its products are used in industries and products, such as aerospace, high-speed rail, MRT systems, solar and wind power, computers, mobile phones, automobiles, home appliances, and industrial products. The...

• Industry: Aluminum
• Sector: Materials
• Founded: 1993
• Employees: 400
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6175

Financial Performance

In 2024, Liton Technology's revenue was 4.23 billion, an increase of 14.94% compared to the previous year's 3.68 billion. Earnings were 469.25 million, an increase of 59.14%.